ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 1,300 | +8.3% | 0.00% | -100.0% |
| Q2 2023 | $24 | +14.3% | 1,200 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $21 | +162.5% | 1,200 | +207.7% | 0.00% | +100.0% |
| Q4 2022 | $8 | -100.0% | 390 | -85.6% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | -89.7% | 2,700 | -95.2% | 0.00% | -90.9% |
| Q2 2022 | $156,000 | +372.7% | 56,518 | +1469.9% | 0.01% | +1000.0% |
| Q1 2022 | $33,000 | +371.4% | 3,600 | +227.3% | 0.00% | – |
| Q4 2021 | $7,000 | +16.7% | 1,100 | +450.0% | 0.00% | – |
| Q3 2021 | $6,000 | -71.4% | 200 | -75.0% | 0.00% | -100.0% |
| Q2 2021 | $21,000 | +50.0% | 800 | +60.0% | 0.00% | 0.0% |
| Q1 2021 | $14,000 | +600.0% | 500 | -90.4% | 0.00% | – |
| Q2 2020 | $2,000 | -50.0% | 5,200 | +1200.0% | 0.00% | – |
| Q1 2020 | $4,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |